Prevention Bundles for SSIs (PREBUSSI). - Trial NCT05548764
Access comprehensive clinical trial information for NCT05548764 through Pure Global AI's free database. This phase not specified trial is sponsored by Maximos Frountzas and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Maximos Frountzas
National and Kapodistrian University of Athens
Timeline & Enrollment
N/A
Oct 01, 2022
Dec 30, 2023
Primary Outcome
Incidence of SSIs
Summary
Surgical site infections (SSIs) are the most complication after a surgical operation and
 their incidence reaches 20% worldwide. SSIs have been associated to significant morbidity and
 mortality, high ICU admission rates, increased length of hospital stay, high readmission
 rates and raised cost. However, there is no registry for SSIs in Greece so far. In addition,
 it has been considered that almost half of SSIs could be prevented. Therefore, several
 prevention strategies have been suggested by international health organizations, such as WHO
 and NICE, that seem to be effective. The aim of the present study is to investigate the
 effect of 10 prevention bundles on the rate of SSIs, as well their consequences on several
 financial parameters of the Greek healthcare system.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05548764
Non-Device Trial